Tenders of Aok Rheinland Pfalz Saarland Die Gesundheitskasse
Tenders of Aok Rheinland Pfalz Saarland Die Gesundheitskasse
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Laboratory Equipment and Services
Germany
Closing Date31 May 2026
Tender AmountRefer Documents
Germany – Pharmaceutical Products – Abschluss Nicht Exklusiver Rabattverträge Gemäß §§ 130a Abs. 8/130c Abs. 1 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Etanercept (l04ab01) Im Rahmen Eines Sogenannten Open-house-modells.
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Civil And Construction
Germany
Closing Date31 May 2026
Tender AmountRefer Documents
Germany – Pharmaceutical Products – Abschluss Nicht Exklusiver Rabattverträge Gemäß §§ 130a Abs. 8/130c Abs. 1 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Bempedoinsäure (c10ax15) Im Rahmen Eines Sogenannten Open-house-modells.
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Electronics Equipment...+2Electrical Goods and Equipments, Electrical and Electronics
Germany
Closing Date31 May 2026
Tender AmountRefer Documents
Germany – Pharmaceutical Products – Abschluss Nicht Exklusiver Rabattverträge Gemäß §§ 130a Abs. 8/130c Abs. 1 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Ustekinumab (l04ac05) Im Rahmen Eines Sogenannten Open-house-modells.
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Closing Date30 Apr 2026
Tender AmountRefer Documents
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient cariprazine (N05AX15) within the framework of a so-called open-house model.
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Closing Date30 Apr 2026
Tender AmountRefer Documents
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient follitropin alfa (G03GA05) within the framework of a so-called open-house model.
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Closing Date30 Apr 2026
Tender AmountRefer Documents
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient tacrolimus (L04AD02) within the framework of a so-called open-house model.
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Closing Date30 Apr 2026
Tender AmountRefer Documents
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient ganirelix (H01CC01) within the framework of a so-called open-house model.
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Closing Date30 Apr 2026
Tender AmountRefer Documents
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient calcipotriol and betamethasone (D05AX22), excluding ointments within the framework of a so-called open-house model.
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Healthcare and Medicine
Germany
Closing Date30 Apr 2026
Tender AmountRefer Documents
Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient lipegfilgrastim (L03AA14) within the framework of a so-called open-house model.
AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender
Civil And Construction
Germany
Closing Date30 Apr 2026
Tender AmountRefer Documents
Germany – Pharmaceutical Products – Abschluss Nicht Exklusiver Rabattverträge Gemäß §§ 130a Abs. 8/130c Abs. 1 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Mebeverin (a03aa04) Rahmen Eines Sogenannten Open-house-modells.
81-90 of 254 active Tenders